Results 211 to 220 of about 4,937,104 (342)

Circulating Interleukin‐6 Levels and Timing of Acute Ischemic Stroke Onset

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Intravenous thrombolysis is the most widely available effective ischemic stroke treatment, but is approved only if given within 4.5 h from stroke onset. Many patients are not treated because stroke onset time is unknown. We evaluated the cytokine interleukin 6 (IL‐6) in circulating blood after acute ischemic stroke (AIS).
Robert G. Kowalski   +15 more
wiley   +1 more source

In search of the most cost‐effective monitoring strategy for vestibular schwannoma: A decision analytical modelling study [PDF]

open access: hybrid, 2019
Mirre Scholte   +6 more
openalex   +1 more source

An evidence-based review of HR Analytics

open access: yes, 2017
Janet H. Marler, J. Boudreau
semanticscholar   +1 more source

Transformation of an Uncertain Video Search Pipeline to a Sketch-Based Visual Analytics Loop

open access: yesIEEE Transactions on Visualization and Computer Graphics, 2013
P. Legg   +6 more
semanticscholar   +1 more source

Multimodal Autonomic Biomarkers Predict Phenoconversion in Pure Autonomic Failure

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Pure autonomic failure (PAF) presents with autonomic failure without other neurological features. A third develop central neurological features, fulfilling criteria for multiple system atrophy (MSA) and Lewy body diseases (LBD), including Parkinson's disease and Dementia with Lewy bodies.
S. Koay   +12 more
wiley   +1 more source

Derivative-Free Direct Search Optimization Method for Enhancing Performance of Analytical Design Approach-Based Digital Controller for Switching Regulator [PDF]

open access: gold, 2019
Ghulam Abbas   +9 more
openalex   +1 more source

Cognitive Resilience in Apolipoprotein ε4 Carrier Women Predicted by Neuron‐Derived Extracellular Vesicles

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The Apolipoprotein (APOE) ε4 allele is the strongest genetic risk factor for late‐onset Alzheimer's disease (AD); however, many ε4 carriers remain cognitively intact into old age. Leveraging plasma neuron‐derived extracellular vesicles (NDEVs), we sought to identify biomarkers of cognitive resilience and their interplay with APOE ...
Apostolos Manolopoulos   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy